FDA: Effectiveness of Oral Phenylephrine in over-the-counter cough and cold products
[9/14/2023] This is the LINK to The FDA Report where the Non-prescription Drug Advisory Committee met Sept. 11-12, 2023, to discuss the...
FDA: Effectiveness of Oral Phenylephrine in over-the-counter cough and cold products
FDA clarifies results of recent advisory committee meeting on oral phenylephrine
As Lyme Disease Expands Its Reach, New Research Offers Hope
High Blood Pressure More Likely after COVID-19 than Flu
Toward Gerineuropalliative Care for Patients with Dementia
Addressing the Complex Driving Needs of an Aging Population
Psychedelic Therapy—A New Paradigm of Care for Mental Health
Single-Dose Psilocybin Treatment for Major Depressive Disorder
Sandoz: positive results for Neovascular Age-related Macular Degeneration ... and more
RECALL: Dr. Berne's Organic Castor Oil Eye Drops AND MSM MIST -Bacterial and Fungal Contamination
Multiple Sclerosis: Sandoz’s Tyruko® first and only FDA approved biosimilar for relapsing MS forms
The Paradoxical Decline of Geriatric Medicine as a Profession
Severe COVID-19 may lead to long-term innate immune system changes
Meta-Analysis: Most Effective Exercises for reducing blood pressure
CDC/FDA recommends stop using Recalled EzriCare Artificial Tears + 2 others
Salmonella Outbreaks Linked to Backyard Poultry - CDC
The Vexing Problem of Preterm Birth Prevention
State Restrictions and Geographic Access to Gender-Affirming Care for Transgender Youth
Using EEG to Monitor Brain Wave Transitions Could Reduce Postoperative Cognitive Issues
CDC Recommends Single-Visit Hepatitis C Testing